Esi M. Morgan Dewitt, MD, MSCE

Related Content

Locations

• Duke Lupus Clinic

Department / Division:
Pediatrics / Rheumatology

Address:
DUMC 3212
Durham, NC 27710

Appointment Telephone:
919-668-4000

Office Telephone:
919-684-6575

Fax Telephone:
919-684-6616

• MD, Washington University School of Medicine, Missouri, 1999

• Pediatrics, Children's Hospital of Philadelphia, Pennsylvania, 1999-2002

• Pediatric Rheumatology, Children's Hospital of Philadelphia, Pennsylvania, 2002-2005

• MSCE, University of Pennsylvania, 2005

Clinical Interests:
Childhood rheumatic diseases, juvenile idiopathic arthritis, use of patient-reported outcome measures in clinical care, medication safety

Research Interests:
Dr.  Morgan DeWitt’s research is in the areas of health services research and pharmacoepidemiology.  Themes of her work include improving outcome measures of drug efficacy in pediatric clinical trials and outcome measures in clinical practice, variability in physician prescribing practices, health disparities, pharmacoeconomic studies and medication safety.  Current research projects include participation in the NIH Roadmap PROMIS (Patient Reported Outcomes Measurement Information System) project in collaboration with Duke, UNC, and other investigators in development of a computerized pediatric patient reported outcomes item bank using modern psychometric theory.   The resultant product will be the basis for computerized adaptive testing for health assessment in pediatric patients.  An important aspect of the study will be an assessment of the agreement between parent and pediatric patient self-report of their health status.    With support from the Arthritis Foundation Engalitcheff Outcomes Initiative, Dr. Morgan DeWitt is also researching disparities in prescription of biologic therapies for treatment of rheumatoid arthritis (RA), and studying the pharmacoeconomics of biologics used for treatment of RA.   This research is conducted with collaborators at the Center for Clinical and Genetic Economics (CCGE) of the Duke Clinical Research Institute.  She is also involved in a collaborative quality improvement initiative in pediatric rheumatology in conjunction with CARRA (Childhood Arthritis and Rheumatology Research Alliance).

Representative Publications:
DeWitt EM, Ardoin SP, Rabinovich CE, Schanberg LE. Clinical trials in pediatric rheumatology: comment on the editorial by Lehman. Arthritis Rheum. 2008 Apr;58(4):1202-3; author reply 1203. (2008) Abstract

DeWitt EM. Medication safety in children with arthritis. N C Med J. 2007 Nov-Dec;68(6):427-9. (2007) Abstract

Cahill AM, Baskin KM, Kaye RD, Arabshahi B, Cron RQ, Dewitt EM, Bilaniuk L, Towbin RB. CT-guided percutaneous steroid injection for management of inflammatory arthropathy of the temporomandibular joint in children. AJR Am J Roentgenol. 2007 Jan;188(1):182-6. (2007) Abstract

DeWitt EM, Glick HA, Albert DA, Joffe MM, Wolfe F. Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior. Arch Intern Med. 2006 Jan 9;166(1):57-63. (2006) Abstract

DeWitt EM, Sherry DD, Cron RQ. Pediatric rheumatology for the adult rheumatologist I: therapy and dosing for pediatric rheumatic disorders. J Clin Rheumatol. 2005 Feb;11(1):21-33. (2005) Abstract

Arabshahi B, Dewitt EM, Cahill AM, Kaye RD, Baskin KM, Towbin RB, Cron RQ. Utility of corticosteroid injection for temporomandibular arthritis in children with juvenile idiopathic arthritis. Arthritis Rheum. 2005 Nov;52(11):3563-9. (2005) Abstract